Clinical Trials Browser

Phase 2 × Breast Neoplasms × Omeprazole × Clear all

NCT06150898 2025-06-13

KePreSt

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

NCT02595372 2021-12-15

Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy

Phase 2 Completed

42 enrolled 14 charts

Breast Neoplasms